Close Menu
Skip to main content
GenomeWeb
360Dx
Precision Oncology News
Precision Oncology News
*
*
Show password
Forgot your password?
Subscribe
Contains all of these words:
Business & Policy
Business News
Regulatory News
Reimbursement
Biomarkers
BRCA
EGFR
HER2
KRAS
BRAF
ROS1
ALK
PD-L1
Cancer Specialties
Breast Cancer
Lung Cancer
Colorectal Cancer
Prostate Cancer
Ovarian Cancer
Brain Cancer
Melanoma
Pediatric Cancer
Oncology Trends
Next-Generation Sequencing
Minimal Residual Disease
Microsatellite Instability Testing
Immunotherapy
Liquid Biopsy
Resources
Webinars
White Papers
Conferences & Events
Menu
Home
›
Abbott
Abbott
There is currently no Precision Oncology News content classified with this term.
Breaking
News
Vedanta, Bristol-Myers Squibb to Study Immuno-oncology Combo Therapy for Variety of Cancers
Kura Oncology Reports Positive Interim Data From Phase II Tipifarnib Trial for T-Cell Lymphoma
PAK4 Inhibition Increases Anti-PD-1 Response in Mouse Models Prompting Phase I Trial
AstraZeneca, Merck's Lynparza Approved in China for BRCA-Mutated Ovarian Cancer
Genentech Garners FDA Approval for Tecentriq in Front-Line Lung Cancer Regardless of PD-L1 Status
NCCN Updates Genetic Testing Guidelines for Assessing Breast, Ovarian, Pancreatic Cancer Risk
